| Product Code: ETC7535911 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India acquired angioedema treatment market import shipment depicted a remarkable CAGR from 2020 to 2024. Notably, the growth rate surged significantly between 2023 and 2024, indicating accelerating market expansion. The trend showcases robust momentum and a clear trajectory of rapid growth during the specified periods.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Acquired Angioedema Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Acquired Angioedema Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Acquired Angioedema Treatment Market - Industry Life Cycle |
3.4 India Acquired Angioedema Treatment Market - Porter's Five Forces |
3.5 India Acquired Angioedema Treatment Market Revenues & Volume Share, By Typeof Angioedema, 2021 & 2031F |
3.6 India Acquired Angioedema Treatment Market Revenues & Volume Share, By Treatment Modalities, 2021 & 2031F |
3.7 India Acquired Angioedema Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Acquired Angioedema Treatment Market Revenues & Volume Share, By End-User, 2021 & 2031F |
3.9 India Acquired Angioedema Treatment Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.10 India Acquired Angioedema Treatment Market Revenues & Volume Share, By Cause of Angioedema, 2021 & 2031F |
3.11 India Acquired Angioedema Treatment Market Revenues & Volume Share, By Price Range, 2021 & 2031F |
4 India Acquired Angioedema Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about acquired angioedema and its treatment options in India |
4.2.2 Growing healthcare expenditure and improving healthcare infrastructure in the country |
4.2.3 Rising prevalence of acquired angioedema cases in India |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of advanced treatment options for acquired angioedema in India |
4.3.2 High cost associated with the treatment and management of acquired angioedema |
4.3.3 Lack of skilled healthcare professionals specializing in acquired angioedema treatment in India |
5 India Acquired Angioedema Treatment Market Trends |
6 India Acquired Angioedema Treatment Market, By Types |
6.1 India Acquired Angioedema Treatment Market, By Typeof Angioedema |
6.1.1 Overview and Analysis |
6.1.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Typeof Angioedema, 2021- 2031F |
6.1.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Hereditary Angioedema (HAE), 2021- 2031F |
6.1.4 India Acquired Angioedema Treatment Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.2 India Acquired Angioedema Treatment Market, By Treatment Modalities |
6.2.1 Overview and Analysis |
6.2.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Pharmacological Therapies, 2021- 2031F |
6.2.3 India Acquired Angioedema Treatment Market Revenues & Volume, By C1 Inhibitors Replacement Therapy, 2021- 2031F |
6.2.4 India Acquired Angioedema Treatment Market Revenues & Volume, By Bradykinin Receptor Antagonists, 2021- 2031F |
6.3 India Acquired Angioedema Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Oral Medications, 2021- 2031F |
6.3.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Injectable Therapies, 2021- 2031F |
6.3.4 India Acquired Angioedema Treatment Market Revenues & Volume, By Topical Treatments, 2021- 2031F |
6.4 India Acquired Angioedema Treatment Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.4.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.4.4 India Acquired Angioedema Treatment Market Revenues & Volume, By Specialized Treatment Centers, 2021- 2031F |
6.5 India Acquired Angioedema Treatment Market, By Age Group |
6.5.1 Overview and Analysis |
6.5.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Pediatric Population, 2021- 2031F |
6.5.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Adult Population, 2021- 2031F |
6.6 India Acquired Angioedema Treatment Market, By Cause of Angioedema |
6.6.1 Overview and Analysis |
6.6.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.6.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Non-Allergic Angioedema, 2021- 2031F |
6.7 India Acquired Angioedema Treatment Market, By Price Range |
6.7.1 Overview and Analysis |
6.7.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Standard Therapies, 2021- 2031F |
6.7.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Specialty Therapies, 2021- 2031F |
6.8 India Acquired Angioedema Treatment Market, By Brand |
6.8.1 Overview and Analysis |
6.8.2 India Acquired Angioedema Treatment Market Revenues & Volume, By Leading Brands, 2021- 2031F |
6.8.3 India Acquired Angioedema Treatment Market Revenues & Volume, By Generic Options, 2021- 2031F |
7 India Acquired Angioedema Treatment Market Import-Export Trade Statistics |
7.1 India Acquired Angioedema Treatment Market Export to Major Countries |
7.2 India Acquired Angioedema Treatment Market Imports from Major Countries |
8 India Acquired Angioedema Treatment Market Key Performance Indicators |
8.1 Number of specialized treatment centers for acquired angioedema in India |
8.2 Percentage increase in the adoption of new treatment modalities for acquired angioedema |
8.3 Patient satisfaction rates with the quality of care and treatment outcomes |
8.4 Average time from diagnosis to treatment initiation for acquired angioedema patients in India |
8.5 Number of research studies and clinical trials focused on acquired angioedema treatment in India |
9 India Acquired Angioedema Treatment Market - Opportunity Assessment |
9.1 India Acquired Angioedema Treatment Market Opportunity Assessment, By Typeof Angioedema, 2021 & 2031F |
9.2 India Acquired Angioedema Treatment Market Opportunity Assessment, By Treatment Modalities, 2021 & 2031F |
9.3 India Acquired Angioedema Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Acquired Angioedema Treatment Market Opportunity Assessment, By End-User, 2021 & 2031F |
9.5 India Acquired Angioedema Treatment Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.6 India Acquired Angioedema Treatment Market Opportunity Assessment, By Cause of Angioedema, 2021 & 2031F |
9.7 India Acquired Angioedema Treatment Market Opportunity Assessment, By Price Range, 2021 & 2031F |
9.7 India Acquired Angioedema Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
10 India Acquired Angioedema Treatment Market - Competitive Landscape |
10.1 India Acquired Angioedema Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Acquired Angioedema Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |